Global Blood Therapeutics Inc.
NASDAQ: GBT
$68.49
+$0.00 (+0.0%)
Closing Price on November 2, 2022
GBT Stock Chart and Intraday Price
GBT Stock Data
| Asset Type | ETF |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
GBT Articles
Tuesday’s top analyst upgrades and downgrades included Alphabet, Amazon.com, Americold Realty Trust, Azek, Ball, Corteva, DraftKings, Dun & Bradstreet, Global Blood Therapeutics, Lululemon...
Published:
Last Updated:
Monday's additional top analyst upgrades and downgrades were on Coinbase Global, Global Blood Therapeutics, Grab, Leslie’s, Nektar Therapeutics, Park Hotels & Resorts, Rocket Companies and Roku.
Published:
Tuesday afternoon's top analyst upgrades and downgrades included Alibaba, Apple, AstraZeneca, Canopy Growth, CNX Resources, Murphy Oil, Ross Stores and Tesla.
Published:
Wednesday's top analyst upgrades and downgrades included Chevron, Clorox, Corsair Gaming, Coursera, Schlumberger and Under Armour.
Published:
Monday’s top analyst upgrades and downgrades included GoDaddy, Groupon, Resmed, Salesforce, Shopify, Squarespace, Yelp, and more.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including NovoCure, Synchrony, Twitter and Yum! Brands.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including AT&T, Expedia, Mattel and Urban Outfitters.
Published: